{"id":"https://openalex.org/W6731183","doi":"https://doi.org/10.1097/00001622-199801000-00010","title":"Advances in chemotherapy and biotherapy of endocrine tumors","display_name":"Advances in chemotherapy and biotherapy of endocrine tumors","alternate_titles":[],"publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W6731183","doi":"https://doi.org/10.1097/00001622-199801000-00010","mag":"6731183","pmid":"https://pubmed.ncbi.nlm.nih.gov/9466486"},"language":"en","primary_location":{"id":"doi:10.1097/00001622-199801000-00010","doi":"https://doi.org/10.1097/00001622-199801000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001622-199801000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S179395531","display_name":"Current Opinion in Oncology","issn_l":"1040-8746","issn":["1040-8746","1080-8140","1531-703X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W6731183"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110122756","display_name":"Kjell \u00d6berg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kjell \u00d6berg","raw_affiliation_strings":["Head Endocrine Oncology Unit, Department of Internal Medicine, University Hospital, S-851 85 Uppsala, Sweden","Department of Internal Medicine, University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Head Endocrine Oncology Unit, Department of Internal Medicine, University Hospital, S-851 85 Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]},{"raw_affiliation_string":"Department of Internal Medicine, University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110122756"],"corresponding_institution_ids":["https://openalex.org/I1342360035"],"apc_list":null,"apc_paid":null,"fwci":3.1285,"has_fulltext":false,"cited_by_count":66,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.91922214,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"10","issue":"1","first_page":"58","last_page":"66"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.996999979019165},{"id":"https://openalex.org/keywords/endocrine-tumors","display_name":"endocrine tumors","score":0.8740000128746033},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.9039999842643738},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.8880000114440918},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.984000027179718},{"id":"https://openalex.org/keywords/somatostatin-analogs","display_name":"somatostatin analogues","score":0.9980000257492065},{"id":"https://openalex.org/keywords/somatostatin-receptor-subtypes","display_name":"somatostatin receptor subtypes","score":0.8840000033378601},{"id":"https://openalex.org/keywords/pancreatic-neuroendocrine-tumors","display_name":"pancreatic neuroendocrine tumors","score":0.8240000009536743},{"id":"https://openalex.org/keywords/midgut-carcinoid","display_name":"midgut carcinoid","score":0.996999979019165},{"id":"https://openalex.org/keywords/liver-embolization","display_name":"liver embolization","score":0.7450000047683716},{"id":"https://openalex.org/keywords/transarterial-chemoembolization","display_name":"transarterial chemoembolization","score":0.9950000047683716},{"id":"https://openalex.org/keywords/131i-mibg","display_name":"131I-MIBG","score":0.8960000276565552},{"id":"https://openalex.org/keywords/targeted-radiotherapy","display_name":"targeted radiotherapy","score":0.5899999737739563},{"id":"https://openalex.org/keywords/multimodal-treatment","display_name":"multimodal therapy","score":0.7559999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8378034234046936},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.8373436331748962},{"id":"https://openalex.org/C2781025020","wikidata":"https://www.wikidata.org/wiki/Q419935","display_name":"Octreotide","level":3,"score":0.6897376179695129},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6169711947441101},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.5935280323028564},{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.5765668749809265},{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.5577535629272461},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.5080764293670654},{"id":"https://openalex.org/C170774537","wikidata":"https://www.wikidata.org/wiki/Q2533722","display_name":"Foregut","level":2,"score":0.4473860263824463},{"id":"https://openalex.org/C2781283050","wikidata":"https://www.wikidata.org/wiki/Q786852","display_name":"Gastrinoma","level":4,"score":0.44476425647735596},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4427492022514343},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44205379486083984},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4332071542739868},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42202839255332947},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33447521924972534},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2677057385444641},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.2282317578792572},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18124991655349731},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.10530069470405579},{"id":"https://openalex.org/C105702510","wikidata":"https://www.wikidata.org/wiki/Q514","display_name":"Anatomy","level":1,"score":0.0},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.0},{"id":"https://openalex.org/C2776986829","wikidata":"https://www.wikidata.org/wiki/Q407181","display_name":"Gastrin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D002276","descriptor_name":"Carcinoid Tumor","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002276","descriptor_name":"Carcinoid Tumor","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D004701","descriptor_name":"Endocrine Gland Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004701","descriptor_name":"Endocrine Gland Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D013004","descriptor_name":"Somatostatin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013004","descriptor_name":"Somatostatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017481","descriptor_name":"Receptors, Somatostatin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018761","descriptor_name":"Multiple Endocrine Neoplasia Type 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001622-199801000-00010","doi":"https://doi.org/10.1097/00001622-199801000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001622-199801000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S179395531","display_name":"Current Opinion in Oncology","issn_l":"1040-8746","issn":["1040-8746","1080-8140","1531-703X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Oncology","raw_type":"journal-article"},{"id":"pmid:9466486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9466486","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2398048903","https://openalex.org/W2165147224","https://openalex.org/W2143529573","https://openalex.org/W2411232292","https://openalex.org/W2071032863","https://openalex.org/W2007240908","https://openalex.org/W2508392077","https://openalex.org/W2463978248","https://openalex.org/W1685424159"],"abstract_inverted_index":{"Chemotherapy":[0],"was":[1,126],"considered":[2,47],"the":[3,11,16,30,39,73,98,136,160,203,206],"standard":[4],"for":[5,67,113,121,159],"treatment":[6,42,82,151,227,242],"of":[7,33,41,64,75,110,135,138,152,228],"neuroendocrine":[8,35,51,139,153,229],"tumors":[9,140,154,170,233],"during":[10],"1970s":[12],"and":[13,21,27,43,108,129,141,171,179,199,221,231,238],"1980s.":[14],"During":[15],"1980s":[17],"both":[18],"interferon":[19,177],"alfa":[20,178],"somatostatin":[22,180],"analogue":[23],"therapies":[24],"were":[25],"developed":[26],"significantly":[28],"improved":[29],"clinical":[31],"management":[32],"malignant":[34,167],"tumors.":[36],"Surgery":[37],"remains":[38],"cornerstone":[40],"should":[44],"always":[45,63],"be":[46,194,215],"in":[48,80,97,105,184,205],"patients":[49,68],"with":[50],"tumors,":[52,164],"even":[53],"if":[54],"a":[55,235],"cure":[56],"is":[57,62,155,182,243],"not":[58],"possible.":[59],"Tumor":[60],"reduction":[61],"beneficial":[65],"value":[66],"undergoing":[69],"medical":[70,81,150,241],"treatment.":[71],"Since":[72],"introduction":[74],"biotherapy,":[76,175],"no":[77],"real":[78],"breakthrough":[79],"has":[83],"come":[84],"forward,":[85],"but":[86],"new":[87,117,143],"insights":[88,144],"into":[89,145],"tumor":[90,106,146],"biology":[91],"will":[92,131],"probably":[93],"improve":[94],"therapeutic":[95],"regimens":[96],"near":[99],"future.":[100],"Somatostatin":[101],"subtype":[102],"receptor":[103],"determination":[104],"tissues":[107],"development":[109,137],"subtype-specific":[111],"analogues":[112],"therapy":[114],"are":[115],"two":[116],"approaches.":[118],"The":[119,148,226],"gene":[120],"multiple":[122],"neoplasia":[123],"type":[124],"I":[125],"cloned":[127],"recently,":[128],"it":[130],"increase":[132],"our":[133],"understanding":[134],"give":[142],"pathophysiology.":[147],"current":[149],"based":[156],"on":[157],"chemotherapy":[158],"more":[161,239],"highly":[162],"proliferating":[163],"such":[165,187,217],"as":[166,188,218],"endocrine":[168],"pancreatic":[169,232],"foregut":[172],"carcinoids,":[173],"whereas":[174],"including":[176],"analogues,":[181],"used":[183],"slow-growing":[185],"neoplasms":[186],"midgut":[189],"carcinoids.":[190],"These":[191],"treatments":[192,210],"can":[193,214],"supplemented":[195],"by":[196],"liver":[197],"embolizations":[198],"chemoembolization":[200],"to":[201],"reduce":[202],"masses":[204],"liver.":[207],"When":[208],"these":[209],"fail,":[211],"tumor-targeted":[212],"irradiation":[213],"attempted,":[216],"131I-MIBG":[219],"(metaiodobenzylguanidine)":[220],"90Y":[222],"DOTA":[223],"(1,4,7,10-tetraazacyclododecane-N,N(I),N(II),N(III)-tetraacetic":[224],"acid)-octreotide.":[225],"gut":[230],"necessitates":[234],"multimodal":[236],"approach,":[237],"effective":[240],"being":[244],"developed.":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6731183","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
